Health Care & Life Sciences » Pharmaceuticals | Pivot Pharmaceuticals Inc.

Pivot Pharmaceuticals Inc. | Income Statement

Fiscal year is February-January. All values USD Thousands.
2014
2015
2016
2017
2018
2019
Cost of Goods Sold (COGS) incl. D&A
0.40
0.40
0.30
-
25.10
690.90
Gross Income
0.40
0.40
0.30
-
25.10
690.90
SG&A Expense
65.30
64.10
8,578.60
5,829.10
914.00
4,533.90
EBIT
65.80
-
8,579.00
5,829.10
939.00
5,231.60
Unusual Expense
528.00
785.20
14.40
173.10
451.50
1,050.40
Non Operating Income/Expense
29.90
52.90
13.90
194.60
499.10
45.50
Interest Expense
101.80
226.40
-
81.40
132.80
691.90
Pretax Income
725.50
1,129.00
8,578.40
6,278.20
121.20
7,016.20
Consolidated Net Income
725.50
1,129.00
8,578.40
6,278.20
121.20
7,016.20
Net Income
725.50
1,129.00
8,578.40
6,278.20
121.20
7,016.20
Net Income After Extraordinaries
725.50
1,129.00
8,578.40
6,278.20
121.20
7,016.20
Net Income Available to Common
725.50
1,129.00
8,578.40
6,278.20
121.20
7,016.20
EPS (Basic)
0.19
0.08
0.11
0.08
0.00
0.08
Basic Shares Outstanding
4,828.70
11,600.00
77,718.20
75,315.30
79,898.50
90,201.40
EPS (Diluted)
0.15
0.10
0.11
0.08
0.00
0.08
Diluted Shares Outstanding
4,828.70
11,600.00
77,718.20
75,315.30
79,898.50
90,201.40
EBITDA
65.40
64.10
8,578.60
5,829.10
914.00
4,540.70

About Pivot Pharmaceuticals

View Profile
Address
1275 West 6th Avenue
Vancouver British Columbia V6H 1A6
Canada
Employees -
Website http://www.pivotpharma.com
Updated 07/08/2019
Pivot Pharmaceuticals, Inc. is a development stage biopharmaceutical company. It is engaged in the development and commercialization of therapeutic pharmaceutical products, with a strategic emphasis on the innovation of new therapeutic uses for existing drugs. The company was founded on June 10, 2002 and is headquartered in Vancouver, Canada.